Differential effects of antidepressants on dexamethasone-induced nuclear translocation and expression of glucocorticoid receptor

Brain Research

Volumn 1117, Issue 1, 2006, Pages 125-134

  Funato, Hiromasa ^a   Kobayashi, Ayumi ^a   Watanabe, Yoshifumi ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alternative splicing; Antidepressant; Glucocorticoid receptor; Nuclear translocation; SRp30c

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; GREEN FLUORESCENT PROTEIN; PAROXETINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SRP30C; UNCLASSIFIED DRUG; VERAPAMIL;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA SPLICING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CALCIUM CHANNEL BLOCKERS; CELL NUCLEUS; DEXAMETHASONE; GLUCOCORTICOIDS; GREEN FLUORESCENT PROTEINS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; JURKAT CELLS; MEMBRANE TRANSPORT PROTEINS; PROTEIN ISOFORMS; PROTEIN TRANSPORT; RECEPTORS, GLUCOCORTICOID; RECOMBINANT FUSION PROTEINS; SEROTONIN UPTAKE INHIBITORS; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 33750007417     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.08.029     Document Type: Article

References (52)

1. Bamberger C.M., Bamberger A.M., de Castro M., and Chrousos G.P. Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95 (1995) 2435-2441
2. Barden N., Reul J.M., and Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?. Trends Neurosci. 18 (1995) 6-11
3. Budziszewska B., Jaworska-Feil L., Kajta M., and Lason W. Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription-A possible mechanism. Br. J. Pharmacol. 130 (2000) 1385-1393
4. Calfa G., Kademian S., Ceschin D., Vega G., Rabinovich G.A., and Volosin M. Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment. Psychoneuroendocrinology 28 (2003) 687-701
5. Carlstedt-Duke J. Glucocorticoid receptor beta: view II. Trends Endocrinol .Metab. 10 (1999) 339-342
6. de Kloet E.R., Joels M., and Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev., Neurosci. 6 (2005) 463-475
7. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 (1997) 597-606
8. Fruchter O., Kino T., Zoumakis E., Alesci S., De Martino M., Chrousos G., and Hochberg Z. The human glucocorticoid receptor (GR) isoform β differentially suppresses GRα-induced transactivation stimulated by synthetic glucocorticoids. J. Clin. Endocrinol. Metab. 90 (2005) 3505-3509
9. Glotzbach R.K., and Preskorn S.H. Brain concentrations of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically dosed rats. Psychopharmacology 78 (1982) 25-27
10. Heiske A., Jesberg J., Krieg J.C., and Vedder H. Differential effects of antidepressants on glucocorticoid receptors in human primary blood cells and human monocytic U-937 cells. Neuropsychopharmacology 28 (2003) 807-817
11. Herr A.S., Tsolakidou A.F., Yassouridis A., Holsboer F., and Rein T. Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. Neuroendocrinology 78 (2003) 12-22
12. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
13. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affective Disord. 62 (2001) 77-91
14. Hrdina P.D., and Dubas T.C. Brain distribution and kinetics of desipramine in the rat. Can. J. Physiol. Pharmacol. 59 (1981) 163-167
15. Huntsman M.M., Tran B.V., Potkin S.G., Bunney Jr. W.E., and Jones E.G. Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15066-15071
16. Kino T., Stauber R.H., Resau J.H., Pavlakis G.N., and Chrousos G.P. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. J. Clin. Endocrinol. Metab. 86 (2001) 5600-5608
17. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., and Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol. Psychiatry 9 (2004) 609-620
18. Kralli A., and Yamamoto K.R. An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J. Biol. Chem. 271 (1996) 17152-17156
19. Lai M., McCormick J.A., Chapman K.E., Kelly P.A.T., Seckl J.R., and Yau J.L.W. Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture. Neuroscience 118 (2003) 975-984
20. Lee C.J., and Irizarry K. Alternative splicing in the nervous system: an emerging source of diversity and regulation. Biol. Psychiatry 54 (2003) 771-776
21. Lopez J.F., Chalmers D.T., Little K.I., and Watson S.J. Regulation of serotonin 1A, glucocorticoid and mineralcorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatry 43 (1998) 547-573
22. Lu N.Z., and Cidlowski J.A. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell 18 (2005) 331-342
23. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat. Med. 7 (2001) 541-547
24. Matsubara T., Funato H., Kobayashi A., Nobumoto M., and Watanabe Y. Reduced glucocorticoid receptor α expression in mood disorder patients and first-degree relatives. Biol. Psychiatry 59 (2006) 689-695
25. McEwen B.S. The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 886 (2000) 172-189
26. Miyake K., Fukuchi H., Kitaura T., Kimura M., Sarai K., and Nakahara T. Pharmacokinetics of amitriptyline and its demethylated metabolite in serum and specific brain regions of rats after acute and chronic administration of amitriptyline. J. Pharm. Sci. 79 (1990) 288-291
27. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
28. Oakley R.H., Jewell C.M., Yudt M.R., Bofetiado D.M., and Cidlowski J.A. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J. Biol. Chem. 274 (1999) 27857-27866
29. Okugawa G., Omori K., Suzukawa J., Fujiseki Y., Kinoshita T., and Inagaki C. Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones. J. Neuroendocrinol. 11 (1999) 887-895
30. Okuyama-Tamura M., Mikuni M., and Kojima I. Modulation of the human glucocorticoid receptor function by antidepressive compounds. Neurosci. Lett. 342 (2003) 206-210
31. Pariante C.M., and Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 49 (2001) 391-404
32. Pariante C.M., Pearce B.D., Pisell T.L., Owens M.J., and Miller A.H. Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol. Pharmacol. 52 (1997) 571-581
33. Pariante C.M., Makoff A., Lovestone S., Feroli S., Heyden A., Miller A.H., and Kerwin R.W. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br. J. Pharmacol. 134 (2001) 1335-1343
34. Pariante C.M., Kim R.B., Makoff A., and Kerwin R.W. The antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters. Br. J. Pharmacol. 139 (2003) 1111-1118
35. Pariante C.M., Hye A., Williamson R., Makoff A., Lovestone S., and Kerwin R.W. The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones. Neuropsychopharmacology 28 (2003) 1553-1561
36. Pariante C.M., Thomas S.A., Lovestone S., Makoff A., and Kerwin R.W. Do antidepressants regulate how cortisol affects the brain?. Psychoneuroendocrinology 29 (2004) 423-447
37. Pedersen K.B., and Vedeckis W.V. Quantification and glucocorticoid regulation of glucocorticoid receptor transcripts in two human leukemic cell lines. Biochemistry 42 (2003) 10978-10990
38. Pepin M.C., Beaulieu S., and Barden N. Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures. Mol. Brain Res. 6 (1989) 77-83
39. Pepin M.C., Govindan M.V., and Barden N. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol. Pharmacol. 41 (1992) 1016-1022
40. Pepin M.C., Pothier F., and Barden N. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol. Pharmacol. 42 (1992) 991-995
41. Perlman W.R., Webster M.J., Kleinman J.E., and Weickert C.S. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol. Psychiatry 56 (2004) 844-852
42. Rossby S.P., Nalepa I., Huang M., Perrin C., Burt A.M., Schmidt D.E., Gillespie D.D., and Sulser F. Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant. Brain Res. 687 (1995) 79-82
43. Skolnick P. Antidepressants for the new millennium. Eur. J. Pharmacol. 375 (1999) 31-40
44. Ueda K., Okamura N., Hirai M., Tanigawara Y., Saeki T., Kioka N., Komano T., and Hori R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J. Biol. Chem. 267 (1992) 24248-24252
45. Vedder H., Bening-Abu-Shach U., Lanquillon S., and Krieg J.C. Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone. J. Psychiatr. Res. 33 (1999) 303-308
46. Vottero A., and Chrousos G.P. Glucocorticoid receptor beta: view I. Trends Endocrinol. Metab. 10 (1999) 333-338
47. Wang Y., Wang J., Gao L., Lafyatis R., Stamm S., and Andreadis A. Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c·SRp55 complex that either recruits or antagonizes htra2beta1. J. Biol. Chem. 280 (2005) 14230-14239
48. Webster M.J., Knable M.B., O'Grady J., Orthmann J., and Weickert C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol. Psychiatry 7 (2002) 985-994
49. Whalley L.J., Borthwick N., Copolov D., Dick H., Christie J.E., and Fink G. Glucocorticoid receptors and depression. Br. Med. J. 292 (1986) 859-861
50. Wodarz N., Rupprecht R., Kornhuber J., Schmitz B., Wild K., and Braner H.U. Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression. J. Affective Disord. 22 (1991) 241-248
51. Xu Q., Leung D.Y.M., and Kisich K.O. Serine-arginine-rich protein p30 directs alternative splicing of glucocorticoid receptor pre-mRNA to glucocorticoid receptor β in neutrophils. J. Biol. Chem. 278 (2003) 27112-27118
52. Yehuda R., Boisoneau D., Mason J.W., and Giller E.L. Glucocorticoid receptor number and cortisol excretion in mood, anxiety and psychotic disorders. Biol. Psychiatry 34 (1993) 18-25